Manufacture of pharmaceutical preparations
PHARMAVAX AS
Revenue 2024
NOK 0
Operating profit
NOK −140,000
Equity
NOK −58,000
Incorporated
2021
Share capital
NOK 90,000
Key figures · 2024
Current ratio
1.43
Equity ratio
-5.2%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Return on assets (%%) | -12.6% | |
| Likviditet | ||
| Current ratio | 1.43 | |
| Working capital | 71k | |
| Soliditet | ||
| Equity ratio (%%) | -5.2% | |
| Debt-to-equity ratio | -20.15 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.